Top

Supportive Care in Cancer

Published in:

01-08-2016 | Letter to the editor

Lung cancer stigma and patient-provider communication: a complex association

Authors: O. P. Geerse, M. E. Stegmann, A. J. Berendsen, M. Y. Berger

Published in: Supportive Care in Cancer | Issue 8/2016

Excerpt

Dear Editor: …

Shen MJ, Hamann HA, Thomas AJ, Ostroff JS (2015) Association between patient-provider communication and lung cancer stigma. Support Care Cancer. doi:10.1007/s00520-015-3014-0

Chambers SK, Dunn J, Occhipinti S et al (2012) A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer 12:184. doi:10.1186/1471-2407-12-184 CrossRefPubMedPubMedCentral

Chapple A (2004) Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. BMJ 328:1470. doi:10.1136/bmj.38111.639734.7C CrossRefPubMedPubMedCentral

Hamann HA, Ostroff JS, Marks EG et al (2014) Stigma among patients with lung cancer: a patient-reported measurement model. Psycho-Oncology 23:81–92. doi:10.1002/pon.3371 CrossRefPubMed

Gonzalez BD, Jacobsen PB (2011) Depression in lung cancer patients: the role of perceived stigma. Psycho-Oncology 41:S160–S160. doi:10.1002/pon.1882

Title: Lung cancer stigma and patient-provider communication: a complex association
Authors: O. P. Geerse
M. E. Stegmann
A. J. Berendsen
M. Y. Berger
Publication date: 01-08-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 8/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3132-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2016

From normal response to clinical problem: definition and clinical features of fear of cancer recurrence

The trajectory of neurotoxic side effects’ impact on daily life: a qualitative study

Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study

Engaging Patients as Partners in Developing Patient-Reported Outcome Measures in Cancer—A Review of the Literature

The lived experience of fatigue in children and adolescents with cancer: a systematic review

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

Keynote webinar | Spotlight on antibody–drug conjugates in cancer